Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Sep 14 - Sep 19
Cognitive Decline and Neurodegenerative Conditions Cognitive decline and neurodegenerative conditions show substantial preclinical evidence across multiple pathologies: Stroke models: BPC-157 given during reperfusion counteracted neuronal damage and produced full functional recovery in spatial memory, motor coordination, and balance tests Parkinsons models: MPTP-induced models showed reduced motor symptoms (tremor, rigidity, akinesia), protection of nigrostriatal dopaminergic neurons, and near-complete prevention of mortality Multiple sclerosis models: Cuprizone-induced demyelination resulted in significantly less brain damage and reduced clinical abnormalities when BPC-157 was given in drinking water or intragastrically Traumatic brain injury: Falling weight model studies demonstrated reduced hemorrhage, decreased brain lacerations and edema, and improved early outcomes These diverse models share common mechanisms
The natural form of this vitamin is methylcobalamin which is the same form found in food and is most easily used by the body
Rapid injection can cause localized discomfort and irregular absorption
researchers seeking AHK-CU 100mg peptide research for institutional studies can rely on the HPLC-verified purity and documentation outlined above
Better cognitive function
BPC-157 is a synthetic peptide supplied as a lyophilized research compound for scientific investigation involving cellular signaling pathways, tissue-model analysis, and peptide interaction studies within controlled laboratory environments
US$ 24.24
US$ 29.68
US$ 20.17
US$ 25.57
